Evidence map›Paper›PMID 30934759›Full record

ArticleBiomolecules2019

Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus.

Maryam Paseban, Reza Mohebbati, Saeed Niazmand, Thozhukat Sathyapalan, Amirhossein Sahebkar

Open access · goldAbstract readComparative Study
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Anti-inflammatory, immunomodulatory and anti-oxidant effects ofIranian journal of basic medical sciences · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Maryam PasebanDepartment of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. pasebanm921@mums.ac.ir.
Reza MohebbatiDepartment of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. mohebbatir931@mums.ac.ir.
Saeed NiazmandDepartment of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. niazmands@mums.ac.ir.
Thozhukat SathyapalanDepartment of Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull, Hull, HU3 2RW, UK. Thozhukat.Sathyapalan@hyms.ac.uk.
Amirhossein SahebkarNeurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. amir_saheb2000@yahoo.com.
Mashhad University of Medical Sciences · IRUniversity of Hull · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to investigate the effect of combined intake of a high dose of aspirin, atorvastatin, captopril and metformin on oxidative stress in the brain cortex and hippocampus of streptozotocin (STZ)-induced diabetic rats. MATERIAL AND

methodsRats were randomly divided into the following 11 groups: control and diabetic (D), as well as 9 groups that were treated with metformin (M, 300 mg/kg) or aspirin (ASA, 120 mg/kg) alone or in different combinations with captopril (C, 50 mg/kg) and/or atorvastatin (AT, 40 mg/kg) as follows: (D + M), (D + ASA), (D + M + ASA), (D + M + C), (D + M + AT), (D + M + C + ASA), (D + M + C + AT), (D + M + AT + ASA) and (D + M + C + AT + ASA). The rats in treatment groups received drugs by gavage daily for six weeks. Serum lipid profile and levels of oxidative markers in the brain cortex and hippocampus tissues were evaluated.

resultsThe levels of malondialdehyde in the brain cortex and hippocampus in all the treated groups decreased significantly (

conclusionOur findings showed that the combined use of high-dose aspirin, metformin, captopril and atorvastatin potentiated their antioxidant effects on the brain, and hence could potentially improve cognitive function with their neuroprotective effects on hippocampus.

Indexed as

AnimalsAspirinAtorvastatinCaptoprilDiabetes Mellitus, ExperimentalHypoglycemic AgentsMaleMetforminNeuroprotective AgentsRatsRats, WistarStreptozocinAspirinAtorvastatinCaptoprilHypoglycemic AgentsMetforminNeuroprotective AgentsStreptozocinaspirinatorvastatincaptoprildiabetesmetforminneuroprotectiveoxidative stress

Identifiers

PMID30934759
PMCPMC6523359
OpenAlexW2924651386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.